Dr. Antonio Wolff is a Professor of Oncology at Johns Hopkins University (JHU) and Director, Breast Cancer Trials in the Women’s Malignancies Program at the Johns Hopkins Kimmel Comprehensive Cancer Center (Baltimore, MD, USA). He received his medical degree at the Universidade Federal do Rio de Janeiro in Brazil and trained in medical oncology at Johns Hopkins. He is an Associate Editor of the Journal of Clinical Oncology, Chair of the ECOG-ACRIN Breast Cancer Committee, and Chief Operating Officer for the Translational Breast Cancer Research Consortium (TBCRC). He is a Fellow of the American Society of Clinical Oncology (FASCO) and past Chair of its Clinical Practice Guidelines Committee. His research interests include new treatment strategies, the development and implementation of prognostic and predictive biomarkers (tissue, blood, and imaging) in clinical practice, and on how to improve the survivorship experience of breast cancer patients and their caregivers. He is a Susan G. Komen Scholar, recipient of a Cancer Clinical Investigator Team Leadership Award from the US National Cancer Institute, and was recognized in 2017 by Clarivate Analytics (Thomson Reuters) as one of the world’s most highly cited researchers (top 1% in clinical medicine). He maintains an active clinical practice dedicated to the care of patients with breast cancer and was inducted in 2018 as a member of the JHU Miller Coulson Academy of Clinical Excellence. In 2018, Dr. Wolff was recognized as one of 125 Living the Hopkins Mission Honorees, who were selected for their outstanding dedication to the institution’s core values of excellence and discovery, leadership and integrity, diversity and inclusion, and respect and collegiality, as part of the 125th anniversary celebration of the JHU School of Medicine.

Roxana vive en Alexandria, VA y es madre soltera de un hermoso y milagroso hijo de 12 años. Nació prematuramente a las 27 semanas y pesó 2 lb 9 oz, casi lo pierde, pero ahora está aquí con Roxana, un niño sano de 12 años.

En diciembre de 2015, a la edad de 41 años, le diagnosticaron cáncer de mama en etapa 3. El 8 de febrero de 2016, durante su mastectomía, se extirparon 20 ganglios linfáticos, 13 de los cuales fueron positivos. Al mes siguiente, comenzó 4 meses con quimioterapia y radiación quincenales. El 14 de noviembre de 2016, se volvió a poner en 4 cuando le extirparon los ovarios y los médicos encontraron un tumor maligno en el ovario izquierdo. Buscó segundas y terceras opiniones en los principales centros oncológicos. Esto llevó a una serie de cambios en el plan de tratamiento y medicamentos y, el 2 de julio de 2018, le quitaron el implante y le transfirieron los ganglios linfáticos del abdomen a la mama / axila derecha. Ahora está en su ciclo 49 de una terapia dirigida y ha sido NEAD (sin evidencia de enfermedad) desde que le extirparon los ovarios en noviembre de 2016.

Roxana es una defensora de apoyo entre pares del programa Living Beyond Breast Cancer: Hear My Voice Metastatic Advocacy Program, que ayuda a pacientes de habla inglesa y española. Ha estado aprendiendo más sobre la promoción y ha trabajado en varios proyectos con Komen, Pfizer y AstraZeneca. Se involucró en la promoción porque sintió que no había suficiente representación de la comunidad latina. Al ser bilingüe, quiere servir a su comunidad, mientras pueda y mientras tenga la energía, siendo una voz para aquellos que no hablan inglés.

Como paciente, asiste a un grupo de apoyo llamado Nueva Vida que brinda ayuda y orientación a hispanohablantes que han sido diagnosticados con cáncer. Ella siempre le pide a su otra familia, su familia sobreviviente, que comunique cualquier cosa que quieran que ella comparta en sus grupos de defensa para que se escuchen sus voces. Ella les dice que mientras pueda ayudar, hará todo lo posible para hacerlo.

Le gusta salir a caminar por la mañana; es su forma de meditar. También le encanta pasar tiempo con su familia y amigos, tener buenas conversaciones y simplemente crear recuerdos que durarán toda la vida. Hasta ahora, a lo largo de su viaje, ha podido mantenerse positiva y esperanzada. Ser NEAD le ha ayudado a su salud mental, pero sabe que algún día su salud mental puede no ser tan fuerte y necesitará orientación sobre cómo manejarla.

Dr. Joe W. Gray, a physicist and an engineer by training, holds positions as Professor and Gordon Moore Endowed Chair, Biomedical Engineering Department; Director, OHSU Center for Spatial Systems Biomedicine (OCSSB); and Associate Director for Biophysical Oncology, Knight Cancer Institute at the Oregon Health & Science University. He is also Emeritus Professor, University of California, San Francisco; and Senior Scientist, Lawrence Berkeley National Laboratory.

Gabriela Miller, PT, MSPT es cofundadora de AJ Cancer Rehab Foundation y copropietaria de ACE Cancer Rehab. Es una fisioterapeuta costarricense que vive en Kansas City y ha sido fisioterapeuta durante 11 años, 8 años enfocada en oncología.

Nuestro modelo: enfoque individualizado y centrado en objetivos para controlar cualquier síntoma de cáncer o efecto secundario causado por cirugía, quimioterapia, radiación y terapias dirigidas.

Mi pasión: educar y ayudar a los pacientes y sobrevivientes a vivir la vida que quieren vivir a pesar de los efectos secundarios inducidos por el tratamiento.

Dr. Leone received his MD from Universidad del Salvador, Argentina in 2005. He completed his residency in Internal Medicine at University of Miami Jackson Memorial Hospital in 2011, and went on to complete fellowships in Hematology and Medical Oncology at University of Pittsburgh Medical Center in 2014. He was faculty at University of Iowa Hospitals and Clinics from 2014 through 2017. In 2017, he joined the staff of Brigham and Women's Hospital and Dana-Farber, where he is a medical oncologist and clinical investigator in the Breast Oncology Center. His research focuses on brain metastases, male breast cancer and novel therapies in the treatment of breast cancer.

Dr. Lynce received her medical degree from the Universidade Nova de Lisboa, Portugal in 2004. She completed her residency in Internal Medicine and fellowship in Hematology and Medical Oncology at MedStar Washington Hospital Center/MedStar Georgetown University Hospital in Washington, DC. She was faculty at MedStar Georgetown University Hospital from 2015 to 2020 where she served as the institutional PI for Alliance and the co-PI for the National Capital Area (NCA) Minority/Underserved NCORP. In 2020, she joined the staff of Dana-Farber Cancer Institute and Brigham and Women's Hospital, where she is a medical oncologist and clinical investigator in the Breast Oncology Center. Her research focuses on inflammatory breast cancer, triple-negative breast cancer, BRCA-associated breast cancers and novel therapies in the treatment of breast cancer.

Ashley Fernández fue diagnosticada con cáncer de seno metastásico de novo a la edad de 31 años en abril de 2018. Ashley es una feroz próspera que ha estado viviendo con cáncer de seno metastásico mientras era madre a tiempo completo de su hija Davyn y esposa de su esposo Carlos. Carlos es Fuerza Aérea en Servicio Activo, actualmente están estacionados en Ohio. Ashley también es una poderosa compañera de oración y participa activamente en su iglesia local en Dayton. Ashley ha defendido el cáncer de seno metastásico a través de la Metsquerade de Ohio de 2018, las políticas públicas de Komen, el discurso en público, y ha aparecido y aparecerá en campañas para Metavivor y Komen.

Ashley siempre está buscando oportunidades para educar y capacitar a otros para abogar por su mejor atención médica posible, ¡porque usted vale todas las cosas buenas en este mundo! Ella cree en vivir la vida de manera colorida, llena de aventuras y con intención. Ashley cree que todos los pacientes con cáncer de seno metastásico deberían poder crear recuerdos y cumplir hitos importantes en sus vidas. Es por eso que aboga por la necesidad continua de más fondos para la investigación del cáncer de seno metastásico.

Jamil Rivers was diagnosed with de novo metastatic breast cancer at age 39. Determined to do everything to be here for her children, husband, and family, she researched vigorously how to best prepare for breast cancer and treatment. Jamil started treatment with chemotherapy and supported her health by improving her nutrition with food and supplements and integrative therapies. She is now doing well and on hormonal therapy. Jamil continues to work full-time and live an active life. She believes the research she did to prepare herself for her cancer has been critical in her recovery and overall wellness. She became an advocate to use her voice and experiences to help advance legislative policy, medical research, and to promote care that better meets the needs of individuals impacted by breast cancer, particularly Black and metastatic patients. Jamil is the board president of METAvivor, and on the Board of Directors of Living Beyond Breast Cancer and Healwell. She is a policy and science advocate and metastatic and African-American health equity advisory committee member with Susan G. Komen. She is a member and patient advisor of the Metastatic Breast Cancer Alliance. She is a proposal reviewer for the Breast Cancer Research Program with the Department of Defense and a Project LEAD graduate. She is a Steering Committee member of the Clinical Trials Transformation Initiative.

Jamil also launched The Chrysalis Initiative which provides one-on-coaching and patient navigation support to women with breast cancer, engages in outreach and education for Black women to assess their breast cancer risk and provides training and solutions for providers to ensure equitable care. Through Jamil’s work, she has participated in countless community health events, facilitated the design and funding of two metastatic clinical trials, met with leadership within the Pennsylvania governor’s office and congressional leaders in Washington, D.C., testified to the Food and Drug Administration, and connected numerous women to resources for screenings, treatment, and support. Jamil has been featured in People Magazine, The Philadelphia Inquirer, The Philadelphia Tribune, and Wildfire Magazine; national campaigns for Anthropologie, Novartis, Pfizer, and Cancer and Careers; and on CBS News and Good Morning America. Jamil and her husband, Rick, have three children and reside in Drexel Hill, PA.

Molly Guthrie is responsible for leading Susan G. Komen’s public policy and advocacy efforts through Komen’s Center for Public Policy. As such, Molly oversees Komen’s work to advance key legislative and regulatory objectives at the federal, state and local levels. In this role, she focuses on policy campaigns to increase funding for medical research and screening programs, and ensuring access to affordable, high-quality breast health and cancer care services. In addition to working on policy campaigns, her team works on increasing capacity for public policy and advocacy work with grassroots volunteers.

Molly joined the Washington, D.C. office of Susan G. Komen in 2009, relocating to the Dallas headquarters in late 2012. However, her Komen journey started as a child when the Race for the Cure was brought to Wichita, Kansas in 1990. The Wichita Race was the first Komen co-ed Race and the 4th in Komen’s history. She has been a loyal volunteer ever since.

Prior to joining Komen, Molly attended the University of Kansas where she received her Bachelor of General Studies with an emphasis on political science and communication studies. She worked in the Offices of Governor Kathleen Sebelius and Congressman Dennis Moore during college. Molly resides in Dallas with her husband and two dogs.

Molly Guthrie

Molly Guthrie is responsible for leading Susan G. Komen’s public policy and advocacy efforts through Komen’s Center for Public Policy. As such, Molly oversees Komen’s work to advance key legislative and regulatory objectives at the federal, state and local levels. In this role, she focuses on policy campaigns to increase funding for medical research and screening programs, and ensuring access to affordable, high-quality breast health and cancer care services. In addition to working on policy campaigns, her team works on increasing capacity for public policy and advocacy work with grassroots volunteers.

Molly joined the Washington, D.C. office of Susan G. Komen in 2009, relocating to the Dallas headquarters in late 2012. However, her Komen journey started as a child when the Race for the Cure was brought to Wichita, Kansas in 1990. The Wichita Race was the first Komen co-ed Race and the 4th in Komen’s history. She has been a loyal volunteer ever since.

Prior to joining Komen, Molly attended the University of Kansas where she received her Bachelor of General Studies with an emphasis on political science and communication studies. She worked in the Offices of Governor Kathleen Sebelius and Congressman Dennis Moore during college. Molly resides in Dallas with her husband and two dogs.

Rebecca Birch

As Director for State Policy & Advocacy, Rebecca oversees Komen’s state legislative and advocacy work. In her role, she works with her team to advance key legislative priorities, execute campaigns, develop strategic advocacy plans, and provide training and support to build advocacy capacity. Rebecca joined Komen in February of 2007 as a Public Policy Specialist.

Prior to joining HQ staff, Rebecca served as a Board Member with the Austin Affiliate. Rebecca studied at Texas Women’s University. In her spare time, she is an elected member of the Del Valle ISD Board of Trustees. Rebecca is an avid supporter and volunteer for the increased participation of women in politics and elected office.

Jamil Rivers

Jamil Rivers was diagnosed with de novo metastatic breast cancer at age 39. Determined to do everything to be here for her children, husband, and family, she researched vigorously how to best prepare for breast cancer and treatment. Jamil started treatment with chemotherapy and supported her health by improving her nutrition with food and supplements and integrative therapies. She is now doing well and on hormonal therapy. Jamil continues to work full-time and live an active life. She believes the research she did to prepare herself for her cancer has been critical in her recovery and overall wellness. She became an advocate to use her voice and experiences to help advance legislative policy, medical research, and to promote care that better meets the needs of individuals impacted by breast cancer, particularly Black and metastatic patients. Jamil is the board president of METAvivor, and on the Board of Directors of Living Beyond Breast Cancer and Healwell. She is a policy and science advocate and metastatic and African-American health equity advisory committee member with Susan G. Komen. She is a member and patient advisor of the Metastatic Breast Cancer Alliance. She is a proposal reviewer for the Breast Cancer Research Program with the Department of Defense and a Project LEAD graduate. She is a Steering Committee member of the Clinical Trials Transformation Initiative.

Jamil also launched The Chrysalis Initiative which provides one-on-coaching and patient navigation support to women with breast cancer, engages in outreach and education for Black women to assess their breast cancer risk and provides training and solutions for providers to ensure equitable care. Through Jamil’s work, she has participated in countless community health events, facilitated the design and funding of two metastatic clinical trials, met with leadership within the Pennsylvania governor’s office and congressional leaders in Washington, D.C., testified to the Food and Drug Administration, and connected numerous women to resources for screenings, treatment, and support. Jamil has been featured in People Magazine, The Philadelphia Inquirer, The Philadelphia Tribune, and Wildfire Magazine; national campaigns for Anthropologie, Novartis, Pfizer, and Cancer and Careers; and on CBS News and Good Morning America. Jamil and her husband, Rick, have three children and reside in Drexel Hill, PA.

Tori Geib

Tori was diagnosed in 2016 with Metastatic Breast Cancer (DeNovo), soon after her 30th birthday.

Since diagnosis, she has spent time as a patient advocate for Metastatic Breast Cancer research, funding, and awareness both independently and with organizations such as Susan G Komen, The Ohio Partners for Cancer Control, Living Beyond Breast Cancer, Eli Lilly, Dr. Joe Explains, Cancer Support Community of Columbus, and many other non-profits and health systems. She is an active public speaker, writer, vlogger and blogger; and has been featured/ seen on Time Magazine, Al Jazeera News, AllRecipes.com, Everyday Health, People.com, GoodHousekeeping.com, Health.com, Our American Stories, Good Morning America, GMA Day,and various other national, state and local news programs.

Tori is active in political outreach for metastatic breast cancer and has presented before the Ohio House and Senate Cancer Caucus. She has received proclamations from Ohio Governor John Kasich and Franklin County Commissioners for organizing the first ever Ohio Metastatic Breast Cancer Action Weeks in September of 2018; and the first ever Tori Geib Courage in Action Award named for her advocacy by Komen Columbus in 2019.

She has previously served as the Honorary Chair of Komen Columbus’ Race for the Cure and a mentor for Living Beyond Breast Cancer’s Hear My Voice Program, from she is a proud alumni. She currently serves as the Co-Chair of Patient Centered Services for the Ohio Partners for Cancer Control.

Tori is a graduate of Mount Vernon Nazarene University (BA Criminal Justice & Sociology) and Columbus State Community College (Culinary Arts/ Baking and Pastry & Travel and Tourism). She currently lives in Central Ohio with her family and dog Georgie. She enjoys traveling every chance she can.

Tai Harden-Moore

JD, Florida A&M University College of Law
MBA, Concordia University - Portland

Tai Harden-Moore is a metastatic breast cancer patient and advocate who understands the importance of self-advocacy and addressing health disparities in the African American community.

With an unwavering commitment for addressing race and racism in the healthcare system, Tai is dedicated to ensuring that Black women, and other women or color, are properly cared for and supported throughout their breast cancer journeys.

Initially diagnosed at 31 with stage 3 inflammatory breast cancer, and then at 37 with Metastatic Breast Cancer, Tai has used her advocacy skills and experience to bring attention to the breast cancer disparities that Black women face and finding the interventions needed to save the lives of Black women.

Rebecca Birch

As Director for State Policy & Advocacy, Rebecca oversees Komen’s state legislative and advocacy work. In her role, she works with her team to advance key legislative priorities, execute campaigns, develop strategic advocacy plans, and provide training and support to build advocacy capacity. Rebecca joined Komen in February of 2007 as a Public Policy Specialist.

Prior to joining HQ staff, Rebecca served as a Board Member with the Austin Affiliate. Rebecca studied at Texas Women’s University. In her spare time, she is an elected member of the Del Valle ISD Board of Trustees. Rebecca is an avid supporter and volunteer for the increased participation of women in politics and elected office.